We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

0LB2 Supernus Pharmaceuticals Inc

0.00 (0.00%)
28 Feb 2024 - Closed
Delayed by 15 minutes

Supernus Pharmaceuticals Financial Summary

The current 0LB2 market cap is 3B. The company's latest EPS is USD 1.1113 and P/E is 28.64.

Year End 31 December 2022 20182019202020212022
Total Revenue 408.9M392.76M520.4M586.31M667.75M
Operating Income 144.44M148.57M173.7M86.03M46.12M
Net Income 110.99M113.06M126.95M53.42M60.71M
Year End 31 December 2022 20182019202020212022
Total Assets 977.81M1.16B1.5B1.69B1.7B
Total Liabilities 524.79M564.85M759.24M873.3M816.3M
Total Equity 453.02M595.43M744.86M815.85M886.2M

Cash Flow

Year End 31 December 2022 20182019202020212022
Operating 128.99M143.13M138.4M127.13M116.83M
Investing -413.48M-157.92M-34.7M-81.91M-216.66M
Financing 376.44M3.93M3.56M-130.42M-10.48M
Market Cap 3B
Price to Earnings Ratio 28.64
Price to Sales Ratio 2.6
Price to Cash Ratio 18.67
Price to Book Ratio 1.96
Dividend Yield -

Share Statistics

Shares Outstanding 54.63M
Average Volume (1 week) 33
Average Volume (1 Month) 97
52 Week Change 0.00%
52 Week High 55.00
52 Week Low 55.00
Spread (Intraday) 0 (0%)

Company Info

Company Name Supernus Pharmaceuticals Inc
Address 1209 orange street
wilmington, delaware 19801
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |